MedPath

The Analgesic Effect of Transversus Abdominis Plane (TAP) Block Following Radical Prostatectomy

Not Applicable
Completed
Conditions
Postoperative Pain
Interventions
Drug: Naropine
Other: Placebo
Registration Number
NCT01317368
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

This study is conducted to evaluate different analgesic treatments effect following operation where the prostate gland is surgically removed.

The different treatments the investigators wish to investigate is:

1. Transversus Abdominis Plane (TAP) block.

The TAP block is a rather new method, where a local anaesthetic is deposited between the two inner abdominal muscles. Between these muscles, the nerves that innervates the anterior part of the abdominal wall is situated.

2. Wound infiltration

In this method you deposit a local anaesthetic in the edges of the wound.

3. Placebo

No active local treatment is given.

All patients who wish to participate will be allocated to one of three different treatment groups.

Group 1:

Will receive TAP block with a local anaesthetic and wound infiltration with saline.

Group 2:

Will receive wound infiltration with a local anaesthetic and TAP block with saline.

Group 3:

Will receive TAP block with saline and wound infiltration with saline.

Beside this local treatment all patients will be given systemic Paracetamol (tablet) and Ibuprofen (tablet).

In addition all patients will be given a pump containing morphine. The pump is connected to a button which the patient can activate when they experience pain. This enables the patient to control how much morphine he needs, following the operation.

The hypothesis is that the TAP block is superior in reducing pain and thereby reducing morphine consumption compared to wound infiltration and placebo.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
75
Inclusion Criteria
  • BMI > 18 and < 35
  • Patients who have given their informed consent and have fully understood the nature and limitations of the study
  • Patient who is planned for radical prostatectomy
Exclusion Criteria
  • Not able to cooperate to complete the study
  • Is not able to speak and understand danish
  • Allergy towards the drugs which is used in the study
  • Daily use of strong opioids
  • Infection at the injection area

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TAP blockNaropineTAP block with Ropivacaine Wound infiltration with Saline
Wound infiltrationNaropineTAP block with Saline. Wound infiltration with Ropivacaine.
PlaceboPlaceboTAP block with Saline. Wound infiltration with Saline.
Primary Outcome Measures
NameTimeMethod
A mean visual analogue scale (VAS) pain score 4 hours after surgery when moving from a supine to sitting position between the group receiving active TAP block and the placebo group.4 hours postoperative
Secondary Outcome Measures
NameTimeMethod
VAS pain score at rest, recorded as a Area Under Curve (AUC/24h)Recorded 0-24 hours postoperative

This outcome is assessed 1, 2, 4, 6, 8, 20 and 24 hours postoperative, while the patient is supine in his bed.

This outcome is recorded in and compared between all three groups.

VAS pain score when moving from a supine to a sitting position, recorded as a Area under Curve (AUC/24h)Recorded 0-24 hours postoperative

This outcome is assessed 1, 2, 4, 6, 8, 20 and 24 hours postoperative. This outcome is recorded in and compared between all three groups.

NauseaRecorded 0-24 hours postoperative

On a scale ranging none-mild-moderate-severe at 1, 2, 4, 6, 8, 20, 24 hours postoperative.

This outcome is recorded in and compared between all three groups

SedationRecorded at 0-24 hours postoperative

On a scale ranging none-mild-moderate-severe this outcome is assessed at 1, 2, 4, 6, 8, 20 and 24 hours postoperative.

This outcome is recorded in and compared between all three groups.

VomitingRecorded 0-24 hours postoperative

The number of times the patient produces more than 10 mL of vomit. Recorded at the intervals 0-1, 1-2, 2-4, 4-6, 6-8, 8-20 and 20-24 hours postoperative This outcome is recorded in and compared between all three groups

On-going morphine consumptionRecorded 0-24 postoperative

Recorded at the intervals 0-1, 1-2, 2-4, 4-6, 6-8, 8-20 and 20-24 hours postoperative This outcome is recorded and compared between all three groups

Cumulated morphine consumption24 hours postoperative

This outcome is recorded in and compared between all three groups.

Trial Locations

Locations (1)

The Department of Anaesthesiology, Abdominal Centre, Rigshospitalet

🇩🇰

Copenhagen Ø, Denmark

© Copyright 2025. All Rights Reserved by MedPath